MedTrace Logo

A Study Investigating Properties of the Transversus Abdominis Plane Block

NCT01679392 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2015-03-20

No results posted yet for this study

Summary

In this study we investigate the following properties of the transversus abdominis plane block in healthy volunteers:

1. Cutaneous analgesic distribution
2. Muscular affection
3. Reproducibility

Conditions

  • Anesthesia, Local

Interventions

DRUG

Ropivacaine

Unilateral, single shot, ultrasound-guided, transversus abdominis plane block with 20 ml ropivacaine (7.5 mg/ml)

Sponsors & Collaborators

  • Hillerod Hospital, Denmark

    lead OTHER

Principal Investigators

  • Kion Bo Støving, MD · Hillerod Hospital, Denmark

  • Charlotte Rosenstock, MD · Hillerod Hospital, Denmark

  • Kai Lange, MD · Hillerod Hospital, Denmark

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-03-31
Completion
2013-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01679392 on ClinicalTrials.gov